The incorporation of Internet resources and the use of social media among patients, clinicians, advocates, and researchers in the field of hematology and oncology are growing in importance. Utilization of online information sharing is rising, especially among those involved in rare blood cancer fields, which have generally featured a paucity of reliable, updated information. In particular, blastic plasmacytoid dendritic cell neoplasm (BPDCN), an uncommon, but highly aggressive hematologic malignancy, is one example of a cancer with limited information readily available to the general public. The infrequent incidence of BPDCN, the challenges in recognizing the disease and making a clinico-pathologic diagnosis, and the lack of standard therap...
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare, but highly aggressive hematologic ma...
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare, aggressive type of haematologic prec...
International audienceBlastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive ...
The incorporation of Internet resources and the use of social media among patients, clinicians, advo...
PURPOSE OF REVIEW: Engagement on social media for professional, healthcare-related communication is ...
The advent of social media has led to the ability for individuals all over the world to communicate ...
The social media platform Twitter has provided the hematology/oncology community with unprecedented,...
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive haematological maligna...
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and highly aggressive hematologic mal...
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an extremely rare tumour, which usually affe...
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and highly aggressive hematologic mal...
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive, rare malignancy. Exact incide...
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare, but highly aggressive hematologic ma...
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare, aggressive type of haematologic prec...
International audienceBlastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive ...
The incorporation of Internet resources and the use of social media among patients, clinicians, advo...
PURPOSE OF REVIEW: Engagement on social media for professional, healthcare-related communication is ...
The advent of social media has led to the ability for individuals all over the world to communicate ...
The social media platform Twitter has provided the hematology/oncology community with unprecedented,...
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive haematological maligna...
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and highly aggressive hematologic mal...
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an extremely rare tumour, which usually affe...
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and highly aggressive hematologic mal...
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive, rare malignancy. Exact incide...
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare, but highly aggressive hematologic ma...
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare, aggressive type of haematologic prec...
International audienceBlastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive ...